视网膜中央静脉阻塞是中老年人群发病率较高的致盲性视网膜血管性疾病。传统治疗方法旨在预防并发症的出现和保存现有视力,没有从根本上解除血栓的阻塞作用。全身应用肝素、华法令或链激酶溶栓药物已被证实对提高视力没有明确帮助,并且存在全身或局部出血的风险。学者们从新的角度进行溶栓方法的改进,有可行性并取得一定效果。对视网膜中央静脉阻塞的溶栓治疗进展作一综述。 Central retinal vein occlusion is a blinding retinal vascular disease with a high prevalence in the elderly population. The traditional treatment is designed to prevent the emergence of complications and preserve existing vision, did not fundamentally lift the blockage of thrombus. Systemic use of heparin, warfarin, or streptokinase thrombolytics has been shown not to be clearly helpful in improving visual acuity and there is a risk of systemic or local bleeding. Scholars from a new perspective to improve the thrombolytic method, it is feasible and achieved some results. The progress of thrombolytic therapy of central retinal vein occlusion is reviewed.